Skip to main content
. Author manuscript; available in PMC: 2016 Apr 12.
Published in final edited form as: Bone Marrow Transplant. 2009 Dec 7;45(7):1212–1219. doi: 10.1038/bmt.2009.329

Figure 4. Time to first HCMV load >200 genomes/ml blood according to Campath in vivo use.

Figure 4

The horizontal bar indicates the median value of each dataset. The median time to HCMV DNAamia in the group not receiving Campath in vivo (n=33) was 51 days (range 0 to 206 days), for the group receiving Campath-1G (n=11) was 27 days (range 3 to 56 days), and for the group receiving Campath-1H (n=20) was 33 days (range 4 to 106 days). Significant differences were apparent in time to first HCMV DNAemia between the Campath-1G group and the non Campath group (p = 0.007, Mann Whitney U Test), and between the Campath-1H group and the non Campath group (p = 0.006, Mann Whitney U Test). The difference between the Campath-1G and Campath-1H groups was not significant (p = 0.97, Mann Whitney U Test).